Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009;104:403 411. doi: 10.1161/CIRCRESAHA.108.190918. 147. Xie Z, Lau K, Eby B, Lozano P, He C, Pennington B, Li H, Rathi S, Dong Y, Tian R, Kem D, Zou MH. Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes. 2011;60:1770 1778. doi: 10.2337/db10-0351. 148. Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M. Metformin prevents progression of heart failure in dogs: role of AMP- activated protein kinase. Circulation. 2009;119:2568 2577. doi: 10.1161/CIRCULATIONAHA.108.798561. 149. Cittadini A, Napoli R, Monti MG, Rea D, Longobardi S, Netti PA, Walser M, Sam M, Aimaretti G, Isgaard J, Sacc L. Metformin prevents the development of chronic heart failure in the SHHF rat model. Diabetes. 2012;61:944 953. doi: 10.2337/db11-1132. 150. Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M, Shen Q, Zhu Y, Zhang Y. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1- Smad3 signalling pathway. Cardiovasc Res. 2010;87:504 513. doi: 10.1093/cvr/cvq066. 151. Inzucchi SE, Masoudi FA, McGuire DK. Metformin in heart failure. Diabetes Care. 2007;30:e129. doi: 10.2337/dc07-1686. 152. Glucophage (metformin hydrochloride) tablet [package insert]. http://packageinserts.bms.com/pi/pi_glucophage.pdf. Accessed September 29, 2016. 153. Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the set- ting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34:1431 1437. doi: 10.2337/dc10-2361. 154. National Collaborating Centre for Chronic Conditions. Type 2 Diabetes: National Clinical Guideline for Management in Primary and Secondary Care (Update). London, UK: Royal College of Physicians; 2008. 155. Kaul S, Bolger AF, Herrington D, Giugliano RP, Eckel RH. 